Embed

Academic

Authors

Neelanjana Ray

Neelanjana Ray,University of Pennsylvania,Virology,Biochemistry,Immunology

Edit

Neelanjana Ray

University of Pennsylvania

Publications: 10 | Citations: 151

Fields: Virology, Biochemistry, Immunology

Collaborated with 30 co-authors from 2004 to 2010 | Cited by 698 authors

Cumulative Annual

Sort by:

Publications (10)

BibTeX | RIS | RefWorks Download

HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry (Citations: 6)

, , , , , , , , ,

Journal: Aids Research and Human Retroviruses - AIDS RES HUM RETROVIRUS , vol. 26, no. 1, pp. 13-24, 2010

Study of Andes virus entry and neutralization using a pseudovirion system (Citations: 2)

, , , ,

Journal: Journal of Virological Methods - J VIROL METH , vol. 163, no. 2, pp. 416-423, 2010

Inefficient entry of vicriviroc-resistant HIV1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities (Citations: 8)

, , , , , , ,

Journal: Virology , vol. 387, no. 2, pp. 296-302, 2009

HR2 Mutations in Human Immunodeficiency Virus Type 1 gp41 Restore Fusion Kinetics Delayed by HR1 Mutations That Cause Clinical Resistance to Enfuvirtide (Citations: 7)

, ,

Journal: Journal of Virology - J VIROL , vol. 83, no. 7, pp. 2989-2995, 2009

Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100 (Citations: 4)

, , , , , ,

Journal: Journal of Virology - J VIROL , vol. 82, no. 23, pp. 11695-11704, 2008

Sort by:

Citations (151 times by 136 publications)

Transmitted/Founder and Chronic Subtype C HIV1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57412577&selfId1=2885566&selfId2=0&maxNumber=12&query=

Journal: PLOS Pathogens - PLOS PATHOG , vol. 8, no. 5, 2012

Monotonicity constraints and supercritical Neumann problems (Citations: 1)

Journal: Annales De L Institut Henri Poincare-analyse Non Lineaire - ANN INST HENRI POINCARE-ANAL , vol. 28, no. 1, pp. 63-74, 2011

Engineering HIV-Resistant Human CD4+ T Cells with CXCR4Specific Zinc-Finger Nucleases

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57411822&selfId1=2885566&selfId2=0&maxNumber=12&query=

Journal: PLOS Pathogens - PLOS PATHOG , vol. 7, no. 4, 2011

Impact of the HIV1 env Genetic Context outside HR1–HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57396442&selfId1=2885566&selfId2=0&maxNumber=12&query=

Journal: PLOS One , vol. 6, no. 7, 2011

SHIV162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses

, , , , , , , , ,

Journal: PLOS One , vol. 6, no. 12, 2011

Comments

Co-authors (30)

Journals (4)

Keywords (34)

Neelanjana Ray,University of Pennsylvania,Virology,Biochemistry,Immunology

Publications (10)

BibTeX | RIS | RefWorks Download

HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry (Citations: 6)

Study of Andes virus entry and neutralization using a pseudovirion system (Citations: 2)

Inefficient entry of vicriviroc-resistant HIV1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities (Citations: 8)

HR2 Mutations in Human Immunodeficiency Virus Type 1 gp41 Restore Fusion Kinetics Delayed by HR1 Mutations That Cause Clinical Resistance to Enfuvirtide (Citations: 7)

Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100 (Citations: 4)

Citations (151 times by 136 publications)

Transmitted/Founder and Chronic Subtype C HIV1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7

Monotonicity constraints and supercritical Neumann problems (Citations: 1)

Engineering HIV-Resistant Human CD4+ T Cells with CXCR4Specific Zinc-Finger Nucleases

Impact of the HIV1 env Genetic Context outside HR1–HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates

SHIV162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses


	View FAQ about top research areas and Fields of study

Neelanjana Ray,University of Pennsylvania,Virology,Biochemistry,Immunology

Publications (10) BibTeX | RIS | RefWorks Download

HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry (Citations: 6)

Study of Andes virus entry and neutralization using a pseudovirion system (Citations: 2)

Inefficient entry of vicriviroc-resistant HIV1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities (Citations: 8)

HR2 Mutations in Human Immunodeficiency Virus Type 1 gp41 Restore Fusion Kinetics Delayed by HR1 Mutations That Cause Clinical Resistance to Enfuvirtide (Citations: 7)

Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100 (Citations: 4)

Monotonicity constraints and supercritical Neumann problems (Citations: 1)

Publications (10)

BibTeX | RIS | RefWorks Download